Prince Khalid, Sullivan discuss ways to strengthen joint cooperation between KSA and US    Saudi Arabia bags two gold medals, 2 silvers in GCC Games    Saudi Athletes Achieve Great Victories in the 2nd Day of the GCC Games Tournament in Kuwait    Director of Islamic Affairs of Al-Madinah Branch Receives General Mufti of Kosovo    Saudi Arabia Strongly Condemns Terrorist Attacks on Military Base of African Union Peacekeeping Forces in Somalia    Cabinet congratulates Sheikh Mohamed Bin Zayed on becoming UAE president    City Walk Receives Entertainment and Event Enthusiasts within Jeddah Season with Exciting Shows    Historic Jeddah Zone Attracts Visitors By Distinctive and Historical Shows    Jeddah Pier, the greatest amusement park on the sea, welcomes its visitors with delight and joy during the "Jeddah Season."    Riyadh to host first conference of IAEE in Middle East    EU ready to defend Finland and Sweden in event of Russian attack amid NATO bids    Heavy rains trigger floods in northeast India, killing 8    Guterres calls for 'swift formation' of inclusive Lebanese government    'Saudi women's participation in economic activities reach highest level with 35.6%'    UAE president, vice president congratulate King Salman on being discharged from hospital    Kay Mellor: Actress and Fat Friends creator dies aged 71    OIC Secretary General Receives Permanent Representative of Guinea-Bissau to OIC    Jeddah Jungle Welcomes Visitors with Thrilling Safari Experiences    Saudi Stock Exchange Main Index Ends Trading Lower at 12,689.87 Points    DGDA, Riyadh Third Health Cluster Sign MoU to Provide Healthcare Services in Diriyah    Egypt to Host 2022 Annual Meetings of Islamic Development Bank Group in Sharm El Sheikh    Ruler of Ajman Congratulates Custodian of Two Holy Mosques on Being Discharged from Hospital    Foreign direct investment in Saudi Arabia to jump 20 times by 2030: Al-Falih KSA develops business environment through massive reforms    Saudi delegation concludes partnerships with US capacity building companies    How cricket-crazy India scripted world badminton glory    Sri Lanka down to last day of petrol, warns new PM    Asian Shares Advance    Twitter boss hits back on Musk doubts over fake accounts    Abdulghani clinches first gold for Saudi Arabia in Gulf Games    Jazan Hosts West Asian Beach Soccer Championship    Gulf Health Council: Large sunglasses give better UVA protection    Former Australia cricketer Symonds dies aged 46 in car crash    Saudi citizen turns attention to sports after retirement    5 Arab women filmmakers receive Netflix grant    Over 250 Saudi Female and Male Players to Participate in Kuwait 3rd GCC Games on Friday    Saudi Deaf Athletics Team Leaves for Brazil    Bollywood actor's tweet reignited debate over Hindi as India's national language    SFDA Advises to Wash Dates Well Before Eating    SFDA Advises Against Mixing Surplus of Iftar and Suhoor with Different Foods or Surplus from Other Days    Ministry calls on imams to avoid long supplications in Tahajjud Prayer    Nothing wrong with a Muslim celebrating birthdays, says Saudi scholar    Ranbir Kapoor and Alia Bhatt: Bollywood wishes for star couple on wedding    SFDA Warns Against Microbes Accumulation on Coffee when Stored Incorrectly    SFDA: Over-roasting or roasting is not an indication of the level of food and may cause harm to human health    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    Pilgrims Perform Dhuhr and Asr Prayers at Arafat Holy Site    Council of Senior Scholars: Muslim Brothers' Group Don't Represent Method of Islam, rather only Follows its Partisan Objectives, Violating our Graceful Religion    Eid Al-Adha Prayer Performed at the Grand Holy Mosque    

Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.

Britain cuts medicine prices by 7 percent
Published in Saudi Press Agency on 18 - 10 - 2004

Medicine prices in Britain will be cut by 7 percent under a new five-year deal between government and drug makers that will save more than 1.8 billion pounds ($3.30 billion) on the nation's drugs bill.
The move is a further sign of the mounting pressure on pharmaceutical prices around the world as healthcare providers strive to rein in runaway costs.
The price reduction for branded prescription medicines was announced by the Department of Health on Wednesday, confirming recent speculation that a substantial cut was imminent.
The price deal represents the central plank of a new Pharmaceutical Price Regulation Scheme (PPRS) between the department and the Association of the British Pharmaceutical Industry, which represents major companies.
The rolling PPRS arrangement regulates prices of branded drugs and the profits manufacturers are allowed to make on sales to the state health service. The last two agreements resulted in price cuts of 4.5 percent and 2.5 percent respectively.
In return for the price reduction, pharmaceutical companies will get a sweetener in the form of increased research and development allowances.
Under the new scheme, the amount of R&D spending that firms can offset against their permitted profits is increased to 28 percent of sales to the National Health Service (NHS) from 23 percent.
"This new deal is a win-win," said Health Secretary John Reid.
"It is good value for money for the NHS and the taxpayer and it is good for the industry because it provides an incentive for research and innovation."
Reid said that money saved on the drugs bill -- at least 370 million pounds a year -- would be channelled back into frontline healthcare services.
The total NHS drugs bill was 9.5 billion pounds in 2003 but this is expected to rise to around 11 billion in 2005-2006.
Net spending on drugs prescribed by general practitioners, rather than in hospitals, is expected to be around 5.3 billion pounds a year, leading to savings of 1.8 billion over five years, but additional savings should come from sales to hospitals.
The British market represents some 4 percent of global drug sales, making it a relatively small outlet for UK-based groups such as GlaxoSmithKline Plc and AstraZeneca Plc, which make most of their money in the United States.
But company executives want the home environment to remain favourable for investment.
The British price cut follows a wave of similar cost-cutting measures by governments across Europe, most notably in Germany where a 16 percent price reduction for many drugs was instituted earlier this year.

Clic here to read the story from its source.